Gramalil


Indications and Reactions:

Role Indications Reactions
Secondary
Insomnia 13.1%
Restlessness 11.2%
Dementia 9.7%
Dementia Alzheimer's Type 8.5%
Drug Use For Unknown Indication 7.7%
Angina Pectoris 5.4%
Blood Pressure Increased 4.6%
Infection 4.6%
Prophylaxis 3.9%
Depression 3.5%
Anaemia 3.1%
Cerebral Infarction 3.1%
Gastric Ulcer 3.1%
Hypertension 3.1%
Meningitis 3.1%
Polyuria 3.1%
Gastritis Prophylaxis 2.7%
Dyskinesia 2.3%
Product Used For Unknown Indication 2.3%
Dysuria 1.9%
Toxic Epidermal Necrolysis 13.2%
Hepatic Function Abnormal 7.5%
Pyrexia 7.5%
Oedema 5.7%
Off Label Use 5.7%
Parkinsonism 5.7%
Rhabdomyolysis 5.7%
Ventricular Fibrillation 5.7%
Abnormal Behaviour 3.8%
Arrhythmia 3.8%
Cerebral Infarction 3.8%
Delirium 3.8%
Dementia 3.8%
Dysuria 3.8%
Inappropriate Antidiuretic Hormone Secretion 3.8%
Torsade De Pointes 3.8%
Tracheostomy 3.8%
Urine Output 3.8%
White Blood Cell Count Decreased 3.8%
Aplasia Pure Red Cell 1.9%
Concomitant
Hypertension 14.8%
Dementia Alzheimer's Type 9.9%
Product Used For Unknown Indication 7.8%
Insomnia 6.7%
Cerebral Infarction 6.4%
Constipation 5.6%
Dementia 5.5%
Gastritis 5.1%
Depression 5.0%
Parkinson's Disease 4.7%
Drug Use For Unknown Indication 3.7%
Diabetes Mellitus 3.4%
Prophylaxis 3.2%
Psychiatric Symptom 3.0%
Type 2 Diabetes Mellitus 3.0%
Delirium 2.7%
Osteoporosis 2.6%
Acquired Haemophilia 2.3%
Cardiac Failure Chronic 2.3%
Pneumonia 2.3%
White Blood Cell Count Increased 9.7%
Pneumonia Aspiration 7.3%
Vomiting 7.3%
Sudden Death 6.5%
Pneumonia 5.6%
Hypoglycaemia 4.8%
Renal Failure 4.8%
Stupor 4.8%
Syncope 4.8%
Tremor 4.8%
Death 4.0%
Epilepsy 4.0%
Gamma-glutamyltransferase Increased 4.0%
Hypertension 4.0%
Pyrexia 4.0%
Respiratory Failure 4.0%
Restlessness 4.0%
Somnolence 4.0%
White Blood Cell Count Decreased 4.0%
Agitation 3.2%

Drug Data